ESC Premium Access

J-point elevation in subjects with TWI V1-V4 does not differentiate between arrhythmogenic right ventricular cardiomyopathy (ARVC) and healthy athletes when matched for age, sex and ethnicity.

Congress Presentation

About the speaker

Doctor Maria Brosnan

St Vincent's Hospital, Melbourne (Australia)
1 presentation
0 follower

3 more presentations in this session

State of the Art: management of athletes with heart disease

Speaker: Professor S. Sharma (London, GB)

Thumbnail

Prevalence and clinical outcome of arrhythmic mitral valve prolapse in athletes

Speaker: Doctor S. Caselli (Zurich, CH)

Thumbnail

Legal aspects of disqualification recommendations for elite athletes with cardiovascular disease

Speaker: Professor B. Merkely (Budapest, HU)

Thumbnail

Access the full session

Management of athletes with heart disease

Speakers: Doctor M. Brosnan, Professor S. Sharma, Doctor S. Caselli, Professor B. Merkely
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb